Ontology highlight
ABSTRACT:
SUBMITTER: Moussavi-Harami SF
PROVIDER: S-EPMC4405902 | biostudies-literature | 2014
REPOSITORIES: biostudies-literature
Moussavi-Harami Sayyed Farshid SF Wisinski Kari B KB Beebe David J DJ
Journal of patient-centered research and reviews 20140101 2
The role of circulating tumor cells (CTCs) as a marker for disease progression in metastatic cancer is controversial. The current review will serve to summarize the evidence on CTCs as a marker of disease progression in patients with metastatic breast cancer. The immunohistochemistry(IHC)-based CellSearch<sup>®</sup> is the only FDA-approved isolation technique for quantifying CTCs in patients with metastatic breast cancer. We searched PubMed and Web of Knowledge for clinical studies that assess ...[more]